Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2010
04/06/2010US7691367 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release
04/06/2010US7691366 Chimeric CMP-Ang1 molecule
04/06/2010US7691365 Methods of using chimeric coiled coil molecule to treat ischemic disease
04/06/2010CA2533005C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
04/06/2010CA2455510C A hemostatic composition
04/06/2010CA2453507C A controlled release biodegradable gel matrix
04/06/2010CA2413456C Stable polymer aqueous/aqueous emulsion system and uses thereof
04/06/2010CA2406807C Methods and compositions for the prevention and treatment of anemia
04/06/2010CA2399676C Pharmacologically active antiviral peptides and methods of their use
04/06/2010CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing
04/06/2010CA2331274C Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof
04/06/2010CA2280930C Protein markers for lung cancer and use thereof
04/06/2010CA2280873C The use of latency associated peptide in wound healing
04/06/2010CA2271952C Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
04/06/2010CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
04/06/2010CA2252466C Hepatitis b monoclonal antibodies
04/06/2010CA2235393C Therapeutic antiangiogenic endostatin compositions and methods of use
04/06/2010CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells
04/06/2010CA2188919C Monoclonal antibodies which promote central nervous system remyelination
04/06/2010CA2161867C Means for detecting familial colon cancer (fcc)
04/01/2010WO2010037135A2 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them
04/01/2010WO2010036945A2 Nanoemulsion therapeutic compositions and methods of using the same
04/01/2010WO2010036936A2 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents
04/01/2010WO2010036799A1 Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis "
04/01/2010WO2010036711A1 Methods of modulating protein homeostasis, metabolic syndrome, heavy metal intoxication and nrf2 transcription factors
04/01/2010WO2010036141A1 An implantable neuroendoprosthesis system, a method for preparing same and a procedure for performing of a reconstructive neurosurgical operation
04/01/2010WO2010035722A1 Peptide compound and method for producing same
04/01/2010WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic
04/01/2010WO2010035261A2 Amyloid beta-peptides and methods of use thereof
04/01/2010WO2010035259A2 Compositions and methods for diagnosing and treating b-cll
04/01/2010WO2010035122A2 Complex consisting of polysaccharide and an hpb
04/01/2010WO2010034787A1 Antimicrobial peptides
04/01/2010WO2010034786A1 Antimicrobial peptides
04/01/2010WO2010034784A1 Antimicrobial peptides
04/01/2010WO2010034783A1 Antimicrobial peptides
04/01/2010WO2010034779A2 Composition and method for treatment of preterm labor
04/01/2010WO2010034718A1 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
04/01/2010WO2010034514A2 Cfhr1 as a c5 convertase inhibitor for the treatment of autoimmune diseases
04/01/2010WO2010034490A1 Peptide uroaktivin, as an activator of the enzyme urokinase
04/01/2010WO2010034319A1 Magnetite nanoparticles as a single dose treatment for iron deficiency anemia
04/01/2010WO2010034198A1 A method for removing/inactivating virus in glycoprotein
04/01/2010WO2010034176A1 A throbin-like enzyme of agkistrodon acutus
04/01/2010WO2010034041A1 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
04/01/2010WO2010017514A3 Methods of predicting cancer lethality using replikin counts
04/01/2010WO2010013231A3 Coagulation factor modulation for controlling transplant organ size
04/01/2010WO2010013012A3 Hypothermia inducing polypeptides and uses thereof
04/01/2010WO2010008995A3 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
04/01/2010WO2010002453A3 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis
04/01/2010WO2009158033A3 Antagonists of activin-actriia and uses for increasing red blood cell levels
04/01/2010WO2009158007A3 Methods and compositions for therapeutic treatment
04/01/2010WO2009156511A3 N-glycosylated human growth hormone with prolonged circulatory half-life
04/01/2010WO2009154840A3 Compositions and methods using stem cells in cutaneous wound healing
04/01/2010WO2009147234A3 Anxiolytic composition containing alphas1-casein-derived peptides
04/01/2010WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication
04/01/2010WO2009138762A3 Therapeutic use of peptides
04/01/2010WO2009133521A3 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
04/01/2010WO2009130515A3 Method and system for recording and promoting peripheral nerve regeneration
04/01/2010WO2008042800A3 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081793 Therapeutic uses of humanized antibodies against alpha-4 integrin
04/01/2010US20100081709 Isolated snare ykt6 genomic polynucleotide fragments from chomosome 7 and their uses
04/01/2010US20100081705 Methods for slowing familial als disease progression
04/01/2010US20100081624 Selective peptides that inhibit the biological activity of calcineurin
04/01/2010US20100081623 Novel tellurium compounds and their use as immunomodulators
04/01/2010US20100081622 Reduction of parathyroid hormone levels
04/01/2010US20100081621 Crystal structure of the catalytic domain of the viral restriction factor APOBEC3G
04/01/2010US20100081620 Prodomain modulators of adam 10
04/01/2010US20100081618 Transporters Comprising Spaced Arginine Moieties
04/01/2010US20100081617 Therapeutic agent for spinal cord injuries
04/01/2010US20100081616 Extracellular matrix-binding proteins from staphylococcus aureus
04/01/2010US20100081615 Continuation - site directed modification of fviii
04/01/2010US20100081614 Long-acting growth hormone and methods of producing same
04/01/2010US20100081613 Methods and compositions for enhancing memory
04/01/2010US20100081612 Polypeptide derivatives of parathyroid hormone (pth)
04/01/2010US20100081611 Stabilized maml peptides and uses thereof
04/01/2010US20100081610 Matrix metalloproteinase inhibitors
04/01/2010US20100081609 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
04/01/2010US20100081608 Use of Human Chorionic Gonadotropin (hCG) by Oral-Sublingual or Injectable Route as an Appetite-Suppressant Agent.
04/01/2010US20100081193 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
04/01/2010US20100081126 Process for designing inhibitors of influenza virus structural protein-1
04/01/2010US20100080852 Phamaceutical composition comprising nanoparticles and casein
04/01/2010US20100080850 Polypeptide ligands for targeting cartilage and methods of use thereof
04/01/2010US20100080848 Recombinant Lubricin Molecules and Uses Thereof
04/01/2010US20100080845 Cosmetic Methods And Compositions For Repairing Human Skin
04/01/2010US20100080837 Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction
04/01/2010US20100080829 Lyophilized pharmaceutical compositions and methods of making and using same
04/01/2010US20100080820 Preparation of a Therapeutic Composition
04/01/2010US20100080817 HUMAN PAPILLOMAVIRUS / Ii-KEY HYBRIDS AND METHODS OF USE
04/01/2010US20100080815 MN Gene and Protein
04/01/2010US20100080810 Methods of treating diseases with anti-vegf antibodies
04/01/2010US20100080809 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
04/01/2010US20100080807 Methods and Compositions for Treating Viral Hemorrhagic Fever
04/01/2010US20100080804 Methods of treating inflammatory disorders of the lungs
04/01/2010US20100080802 Anti-il-tif antibodies and methods of use
04/01/2010US20100080801 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases
04/01/2010US20100080799 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
04/01/2010US20100080798 Kim-1 antagonists and use to modulate immune system
04/01/2010US20100080797 Therapy procedure for drug delivery for trigeminal pain
04/01/2010US20100080796 Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
04/01/2010US20100080795 Biodegradable thermogelling polymer
1 ... 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 ... 3163